{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:02:35Z","timestamp":1770894155618,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R15HL145573"],"award-info":[{"award-number":["R15HL145573"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jpet.2025.103574","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:16:46Z","timestamp":1745569006000},"page":"103574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Next-generation of antithrombotic therapies: Beyond conventional drugs"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7973-6242","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103574_bib1","article-title":"Managing thrombus formation with EL2-5HTVac: a selective vaccination-based approach targeting the platelet serotonin 5-HT2AR","volume":"392","author":"Alarabi","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103574_bib2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/ATVBAHA.120.315109","article-title":"Targeting thymidine phosphorylase with tipiracil hydrochloride attenuates thrombosis without increasing risk of bleeding in mice","volume":"41","author":"Belcher","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jpet.2025.103574_bib3","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood-2018-09-876086","article-title":"EPHB2 regulates platelet activation","volume":"132","author":"Berndt","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103574_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/0024-3205(88)90047-1","article-title":"Identification of D1-like dopamine receptors on human blood platelets","volume":"42","author":"De Keyser","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.jpet.2025.103574_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev-pharmtox-010814-124438","article-title":"New approaches to inhibiting platelets and coagulation","volume":"55","author":"Depta","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jpet.2025.103574_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/gh.1288","article-title":"The heart of the world","volume":"19","author":"Di Cesare","year":"2024","journal-title":"Glob Heart"},{"key":"10.1016\/j.jpet.2025.103574_bib7","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.4049\/jimmunol.162.5.3022","article-title":"Genetic evidence for functional redundancy of Platelet\/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions","volume":"162","author":"Duncan","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2025.103574_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2014.156","article-title":"Novel antiplatelet agents in acute coronary syndrome","volume":"12","author":"Franchi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jpet.2025.103574_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/HYPERTENSIONAHA.118.11316","article-title":"Therapeutic vaccine against S100A9 (S100 calcium-binding protein A9) inhibits thrombosis without increasing the risk of bleeding in ischemic stroke in mice","volume":"72","author":"Kawano","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jpet.2025.103574_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0002-9440(10)64519-1","article-title":"PECAM-1 (CD31) expression modulates bleeding time in vivo","volume":"157","author":"Mahooti","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jpet.2025.103574_bib11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/ATVBAHA.114.303413","article-title":"Current state and novel approaches of antiplatelet therapy","volume":"35","author":"Metharom","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jpet.2025.103574_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imr.12370","article-title":"The platelet Fc receptor, Fc\u03b3RIIa","volume":"268","author":"Qiao","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jpet.2025.103574_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jth.13910","article-title":"Negative regulators of platelet activation and adhesion","volume":"16","author":"Stefanini","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103574_bib14","article-title":"Virus-like particles: revolutionary platforms for developing vaccines against emerging infectious diseases","volume":"12","author":"Tariq","year":"2021","journal-title":"Front Microbiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525397879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525397879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:31:58Z","timestamp":1762209118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525397879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0022356525397879"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103574","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-generation of antithrombotic therapies: Beyond conventional drugs","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103399","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103574"}}